Vaccination and heterologous immunity: Educating the immune system

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 1, 2014, Pages 62-69

  Gil, Anna ^a   Kenney, Laurie L ^a   Mishra, Rabinarayan ^a   Watkin, Levi B ^a   Aslan, Nuray ^a   Selin, Liisa K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Crossreactive; Heterologous immunity; Neonatal; T cells; Vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; T LYMPHOCYTE RECEPTOR; VACCINIA VACCINE; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS REACTION; HETEROLOGOUS IMMUNITY; HUMAN; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROFLORA; MURINE CYTOMEGALOVIRUS; NONHUMAN; PICHINDE VIRUS; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; INFANT; NEWBORN; VIRUS DISEASES;

ANIMALS; CROSS REACTIONS; HUMANS; IMMUNITY, HETEROLOGOUS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; T-LYMPHOCYTES; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 84928885378     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru198     Document Type: Article

References (91)

1. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect:nonspecific immunomodulation by vaccines. Trends Immunol 2013;34:431-9.
2. Sanchez-Schmitz G, Levy O. Development of newborn and infant vaccines. Sci Transl Med 2011;3:27.
3. Krishnan S, Craven M, Welliver RC et al. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Dis 2003;188:433-9.
4. Kollmann TR, Crabtree J, Rein-Weston A et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009;183:7150-60.
5. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012;37:771-83.
6. Curtsinger JM, Valenzuela JO, Agarwal P et al. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005;174:4465-9.
7. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009;9:185-94.
8. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271:1723-6.
9. Tang J, Li BQ, Ruan J, Zhang LJ. Expression of Foxp3 in CD4+CD25high Treg cells of neonatal cord blood. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2008;24:365-7.
10. Rudd BD, Venturi V, Davenport MP, Nikolich-Zugich J. Evolution of the antigen-specific CD8+ TCR repertoire across the life span: evidence for clonal homogenization of the old TCR repertoire. J Immunol 2011;186:2056-64.
11. Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996;271:1726-8.
12. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;271:1728-30.
13. Haines CJ, Giffon TD, Lu LS et al. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J Exp Med 2009;206:275-85.
14. Bendelac A, Matzinger P, Seder RA et al. Activation events during thymic selection. J Exp Med 1992;175:731-42.
15. Opiela SJ, Koru-Sengul T, Adkins B. Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants. Blood 2009;113:5635-43.
16. Smith NL, Wissink E, Wang J et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol 2014;193:177-84.
17. Cabaniols JP, Fazilleau N, Casrouge A et al. Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med 2001;194:1385-90.
18. Bogue M, Candeias S, Benoist C. A special repertoire of alpha:beta T cells in neonatal mice. EMBO J 1991;10:3647-54.
19. Gavin MA, Bevan MJ. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 1995;3:793-800.
20. Naumov YN, Naumova EN, Yassai MB et al. Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus. J Immunol 2008;181:7407-19.
21. Strutt TM, McKinstry KK, Dibble JP et al. Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med 2010;16:558-64.
22. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002;2:417-26.
23. Selin LK, Wlodarczyk MF, Kraft AR et al. Heterologous immunity:immunopathology, autoimmunity and protection during viral infections. Autoimmunity 2011;44:328-47.
24. Brehm MA, Pinto AK, Daniels KA et al. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 2002;3:627-34.
25. Chen HD, Fraire AE, Joris I et al. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001;2:1067-76.
26. Chen HD, Fraire AE, Joris I et al. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 2003;163:1341-55.
27. Clute SC, Watkin LB, Cornberg M et al. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 2005;115:3602-12.
28. Cornberg M, Clute SC, Watkin LB et al. CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. J Immunol 2010;184:2825-38.
29. Chen AT, Cornberg M, Gras S et al. Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog 2012;8(4):e1002633.
30. Selin LK, Varga SM, Wong IC et al. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 1998;188:1705-15.
31. Cornberg M, Chen AT, Wilkinson LA et al. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J Clin Invest 2006;116:1443-56.
32. Kim SK, Cornberg M, Wang XZ et al. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 2005;201:523-33.
33. Nie S, Lin SJ, Kim SK et al. Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 2010;176:2107-12.
34. Wlodarczyk MF, Kraft AR, Chen HD et al. Anti-IFN-gamma and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive Influenza A-specific memory T cells. J Immunol 2013;190:2736-46.
35. Selin LK, Lin MY, Kraemer KA et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 1999;11:733-42.
36. Selin LK, Vergilis K, Welsh RM, Nahill SR. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 1996;183:2489-99.
37. Welsh RM, Rothman AL. Dengue immune response: low affinity, high febrility. Nature Med 2003;9:820-2.
38. Antunes DA, Rigo MM, Silva JP. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele. Mol Immunol 2011;48:1461-7.
39. Sinigaglia M, Antunes DA, Rigo MM et al. CrossTope: a curate repository of 3D structures of immunogenic peptide: MHC complexes. Database (Oxford) 2013;2013:bat002.
40. Su LF, Kidd BA, Han A et al. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013;38:373-83.
41. Motozono C, Miles JJ, Hasan Z et al. CD8(+) T cell cross-reactivity profiles and HIV-1 immune escape towards an HLA-B35-restricted immunodominant Nef epitope. PLoS One 2013;8(6):e66152.
42. Sewell AK. Why must T cells be cross-reactive? Nat Rev Immunol 2012;12:669-77.
43. Haanan JB, Wolkers MC, Kruisbeek AM, Schumacher TN. Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med 1999;190:1319-28.
44. Maeda K, Toyosaki-Maeda T, Rothman AL, Ennis FA. Identification and analysis for cross-reactivity among hantaviruses of the H-2b-restrictied cytotoxic T-lymphocyte epitopes in Sin Nombre virus nucleocapsid protein. J Gen Virol 2004;85:1909-19.
45. Wedemeyer H, Mizukoshi E, Davis AR et al. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J Virol 2001;75:11392-400.
46. Urbani S, Amadei B, Fisicaro P et al. Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 2005;201:675-80.
47. Chiu C, McCausland M, Sidney J et al. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog 2014 Mar;10(3):e1004008.
48. Selin LK, Brehm MA, Naumov YN et al. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006;211:164-81.
49. Nie S, Cornberg M, Selin LK. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous Immunity. J Immunol 2009;183:6554-60.
50. Kim SK, Brehm MA, Welsh RM, Selin LK. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol 2002;169:90-8.
51. Kraft AR, Wlodarczyk MF, Kenney LL, Selin LK. PC61 (anti-CD25) Treatment inhibits influenza a virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. J Virol 2013;87:12636-47.
52. Cornberg M, Sheridan BS, Saccoccio FM et al. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry. J Virol 2007;81:934-44.
53. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 1994;179:1933-43.
54. Welsh RM, Che JW, Brehm MA, Selin LK. Heterologous immunity between viruses. Immunol Rev 2010;235:244-66.
55. Welsh RM, Selin LK, Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu Rev Immunol 2004;22:711-43.
56. Welsh RM, Kim SK, Cornberg M et al. The privacy of T cell memory to viruses. Curr Top Microbiol Immunol 2006;311:117-53.
57. Shen ZT, Nguyen TT, Daniels KA et al. Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells. J Immunol 2013;191:5139-52.
58. Shen ZT, Brehm MA, Daniels KA et al. Bi-specific MHC heterodimers for characterization of cross-reactive T cells. J Biol Chem 2010;285:33144-53.
59. Clute SC, Naumov YN, Watkin LB et al. Broad cross-reactive TCR repertoires recognizing dissimilar epstein-barr and influenza A virus epitopes. J Immunol 2010;185:6753-64.
60. Selin LK, Welsh RM. Plasticity of T cell memory responses to viruses. Immunity 2004;20:5-16.
61. Selin LK, Cornberg M, Brehm MA et al. CD8 memory T cells:cross-reactivity and heterologous immunity. Semin Immunol 2004;16:33-47.
62. Welsh RM, McNally JM, Brehm MA, Selin LK. Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 2000;270:4-8.
63. Bahl K, Kim SK, Calcagno C et al. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 2006;176:4284-95.
64. Kim SK, Welsh RM. Comprehensive early and lasting loss of memory CD8 T cells and functional memory during acute and persitent viral infections. J Immunol 2004;172:3139-50.
65. Welsh RM, Bahl K,Wang XZ. Apoptosis and loss of virus-specific CD8(+) T-cell memory. Curr Opin Immunol 2004;16:271-6.
66. McNally JM, Zarozinski CC, Lin MYet al. Attrition of bystander CD8 Tcells during virus-induced T cell and interferon responses. J Virol 2001;75:5965-76.
67. Jiang J, Gross D, Nogusa S et al. Depletion of T cells by type I interferon:differences between young and aged mice. J Immunol 2005;175:1820-6.
68. Marshall HD, Urban SL, Welsh RM. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol 2011;85:5929-39.
69. Bahl K, Huebner A, Davis RJ, Welsh RM. Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists. J Virol 2010;84:4866-77.
70. Di Giusto CA, Bernhard JD. Erythema nodosum provoked by hepatitis B vaccine. Lancet 1986;2:1042.
71. Ojaimi S, Buttery JP, Korman TM. Quadrivalent human papillomavirus recombinant vaccine associated lipoatrophy. Vaccine 2009;27:4876-8.
72. Smoller BR,Weishar M, Gray MH. An unusual cutaneous manifestation in Crohn's disease. Arch Pathol Lab Med 1990;6:609-10.
73. Requena L, Requena C. Erythema nodosum. Dermatol Online 2002;8:4.
74. Aaby P, Martins CL, Garly ML, Rodrigues A et al. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open 2012;2(4).
75. Aaby P, Samb B, Simondon F et al. Non-specific beneficial effect of measles immunisation:analysis of mortality studies from developing countries. BMJ 1995;311:481-5.
76. Aaby P, Bhuiya A, Nahar L et al. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003;32:106-16.
77. Aaby P, Biai S, Veirum JE et al. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau. Vaccine 2007;25:1265-9.
78. Shann F. BCG vaccination in developing countries. BMJ 2010; 340:809.
79. Aaby P, Roth A, Ravn H et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011;204:245-52.
80. Biering-Sorensen S, Aaby P, Napirna BM et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012;31:306-8.
81. Mathurin KS, Martens GW, Kornfeld H, Welsh RM. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 2009;83:3528-39.
82. Steenhuis TJ, van Aalderen WM, Bloksma N et al. Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy 2008;38:79-85.
83. Aaby P, Gustafson P, Roth A et al. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine 2006;24:5718-25.
84. Villumsen M, Sorup S, Jess T et al. Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: A Danish case-cohort study. Vaccine 2009;27:6950-80
85. Sorup S, Benn CS, Poulsen A et al. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA 2014;311:826-35.
86. Aaby P, Jensen H, Gomes J et al. The introduction of diphtheriatetanus- pertussis vaccine and child mortality in rural Guinea-Bissau:an observational study. Int J Epidemiol 2004;33:374-80.
87. Aaby P, Jensen H, Rodrigues A et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol 2004;33:367-73.
88. Aaby P, Benn C, Nielsen J et al. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012;2:3.
89. Flanagan KL, van CR, Curtis N. Heterologous ("non-specific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunological mechanisms. Clin Infect Dis 2013;57:283-9
90. Freyne B, Curtis N. Does neonatal BCG vaccination prevent allergic disease in later life? Arch Dis Child 2014;99:182-4.
91. Flanagan KL, van Crevel R, Curtis N et al. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis 2013;57:283-289.